Characteristics | Cancer | HIV | Other diseases |
Number of studies | 48 studies | 23 studies | 9 studies |
Year of publication | |||
<2000 | 19 studies | 10 studies | None |
2000–2010 | 14 studies | 13 studies | 5 studies |
>2010 | 15 studies | None | 4 studies |
Total number of patients | 7220 patients | 2643 patients | 716 patients |
Cancer type | |||
Solid tumours | 38 studies | N/A | N/A |
Solid and haematological malignancies | 3 studies | N/A | N/A |
Not assessable | 7 studies | N/A | N/A |
Stage of disease | |||
Early stage | 2 studies | N/A | N/A |
Advanced stage | 37 studies | N/A | N/A |
Not assessable | 9 studies | N/A | N/A |
Study interventions | |||
Megace_H | 12 studies | 6 studies | 3 studies |
Megace_L | 11 studies | 2 studies | 2 studies |
Megace_H_Com | 4 studies | 2 studies | None |
Megace_L_Com | 5 studies | 1 study | None |
Steroid | 4 studies | None | None |
Androgen | 3 studies | 12 studies | 1 study |
Proinflam | 10 studies | 1 study | None |
ATP | 2 studies | None | None |
Growth_hormone | None | 6 studies | 1 study |
Ghrelin | 2 studies | None | 2 studies |
Ghrelin_mimetic | 6 studies | None | None |
Medroxyprogesterone | 3 studies | None | None |
Dronabinol | 2 studies | 2 studies | None |
Melatonin | 1 study | None | None |
Placebo | 33 studies | 18 studies | 9 studies |
Megace_H (at least 400 mg/day), Megace_L (less than 400 mg/day), Megace_H_Com (at least 400 mg/day) with another cachexia or anorexia treatment agent, Megace_L_Com (less than 400 mg/day) with another cachexia or anorexia treatment agent, Steroid, Androgen, Proinflam, ATP, Growth_hormone, Ghrelin, Ghrelin_mimetic, Medroxyprogesterone, Dronabinol or Melatonin.
Androgen, androgen analogue; Dronabinol, dronabinol; Ghrelin, ghrelin; Ghrelin_mimetic, ghrelin mimetic; Growth_hormone, recombinant human growth hormone ; Medroxyprogesterone, medroxyprogesterone; Megace_H, high-dose megestrol acetate; Megace_H_Com, high-dose megestrol acetate combination; Megace_L, low-dose megestrol acetate; Megace_L_Com, megestrol acetate low-dose combination; Melatonin, melatonin; Proinflam, drug-targeting proinflammatory cytokine; Steroid, corticosteroid analogue.